eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
2/2020
vol. 36
 
Share:
Share:
Case report

New psychopharmacotherapy dilemmas associated with COVID-19 – case report

Jolanta Kucharska-Mazur
1
,
Jędrzej Stańczak
1
,
Jerzy Samochowiec
1

  1. Department of Psychiatry, Pomeranian Medical University in Szczecin
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (2), 149–153
Online publish date: 2021/12/06
Article file
Get citation
 
 
1. Arechin, ChPL, http://www.urpl.gov.pl/sites/default/files/Are chin%20Charakterystyka%20Produktu%20Leczniczego.pdf.
2. Detailed recommendations for interactions with experimen tal COVID-19 therapies. https://www.covid19-druginterac tions.org/, University of Liverpool.
3. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 as sociated pneumonia in clinical studies. Biosci Trends. 2020 Mar 16; 14(1): 72–73. Doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
4. Saleh M, Gabriels J, Chang D, Kim BS, Mansoor A, Mahmood E, Makker P, Ismail H, Goldner B, Willner J, Beldner S, Mitra R, John R, Chinitz J, Skipitaris N, Mountantonakis S, Epstein LM. The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol. 2020 Apr 29. doi: 10.1161/CIRCEP.120.008662.
5. Touret F, Lamballerie X. Of chloroquine and COVID-19, Antiviral Res. 2020 May; 177: 104762. Doi: 10.1016/j.anti viral.2020.104762.
6. Uvais NA. The Risks of Prescribing Hyodroxychloroquine in COVID-19-Infected Patients With Schizophrenia. Prim Care Companion CNS Disord. 2020 Apr 30;22(3). pii: 20com02635. Doi: 10.4088/PCC.20com02635

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.